Meanwhile, we obtained an optimum TBILA cut-off value of 0.923 (sensitivity, 64.7%; specificity, 80.7%) and AGAP2-AS1 cut-off value of 1.12 (sensitivity, 66.7%; specificity, 73.3%) for NSCLC diagnosis, respectively. This evidence concerns the gene AGAP2 and non-small cell lung carcinoma.